Jade Biosciences Inc.
JBIO | NASDAQ
$13.73
-$0.33 (-2.35%)
Nov 2, 2026, 12:36 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.80 | -1.09 | -7.89 | -13.92 | -12.52 | -57.08 |
PEG Ratio | 0.04 | 0.07 | -0.22 | -0.11 | -0.09 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.46 | 0.99 | 5.44 | 5.66 | 1.67 | 189.49 |
P/FCF Ratio | -5.10 | -1.06 | -10.47 | -18.24 | -10.44 | -70.91 |
P/OCF Ratio | -5.11 | -1.06 | -10.49 | -18.33 | -10.50 | -70.91 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0.01 | 0.01 | 0.01 | 0 | n/a |
Quick Ratio | 20.33 | 20.93 | 7.04 | 16.90 | 68.37 | 2.64 |
Current Ratio | 20.33 | 20.93 | 7.04 | 16.90 | 68.37 | 2.64 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -118.52 |
Return on Equity | -38.32% | -91.10% | -69% | -40.64% | -13.32% | -326.79% |
Return on Assets | -36.43% | -86.68% | -59.27% | -38.07% | -13.09% | -203.84% |
Return on Invested Capital | -34.07% | -96.98% | -73.87% | -41.62% | -13.31% | -302.24% |
Dividend Yield | 15.55% | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | -59.07% | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove JBIO